AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Q32 Bio Inc. Director's Dealing 2024

Sep 28, 2024

34891_dirs_2024-09-27_ee49a448-5881-498b-8e63-8169c05c0504.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Q32 Bio Inc. (QTTB)
CIK: 0001661998
Period of Report: 2024-09-25

Reporting Person: Lundberg Sven Ante (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-09-25	Stock Option (Right to Buy)	$44.40	A	1316	Acquired	2034-09-24	Common Stock (1316)	Direct

Footnotes

F1: The shares underlying this option vest in three equal quarterly installments on each of June 30, 2024, September 30, 2024 and December 31, 2024.